In this review, we discuss recent findings on modifications to the primary metabolic pathway that promotes cancer growth, such as endogenous succinate dehydrogenase SDH inhibitors that lead to succinate accumulation or dysregulation of (SDH). This evidence concerns the gene SDHB and cancer.